Innate immune response triggered by triacyl lipid A is dependent on phospholipid transfer protein (PLTP) gene expression

FASEB Journal

Volumn 24, Issue 9, 2010, Pages 3544-3554

  Gautier, Thomas ^a   Paul, Catherine ^a,b   Deckert, Valérie ^a   Desrumaux, Catherine ^a   Klein, Alexis ^a   Labbé, Jérôme ^a,b   Le Guern, Naig ^a   Athias, Anne ^a   Monier, Serge ^a   Hammann, Arlette ^a   Bettaieb, Ali ^a,b   Jeannin, Jean François ^a,b   Lagrost, Laurent ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b PSL RESEARCH UNIVERSITY   (France)

Author keywords

Cancer; Inflammation; Lipid transfer protein; Lipopolysaccharide; Lipoprotein

Indexed keywords

HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; LIPID A DERIVATIVE; OM 174; PHOSPHOLIPID TRANSFER PROTEIN; TRIACYL LIPID A DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DRUG CLEARANCE; DRUG EFFECT; DRUG PROTEIN BINDING; FEMALE; GENE EXPRESSION; INNATE IMMUNITY; MEAN RESIDENCE TIME; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION;

ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; CHEMOKINE CCL2; CYTOKINES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; LIPID A; MELANOMA, EXPERIMENTAL; MICE; MICE, MUTANT STRAINS; PHOSPHOLIPID TRANSFER PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS;

EID: 77956636120     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-152876     Document Type: Article

References (43)

1. Miller, S. I., Ernst, R. K., and Bader, M. W. (2005) LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3, 36-46
2. Garay, R. P., Viens, P., Bauer, J., Normier, G., Bardou, M., Jeannin, J. F., and Chiavaroli, C. (2007) Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help. Eur. J. Pharmacol. 563, 1-17 (Pubitemid 46628799)
3. Casella, C. R., and Mitchell, T. C. (2008) Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell. Mol. Life Sci. 65, 3231-3240
4. Sprong, T., Netea, M. G., van der Ley, P., Verver-Jansen, T. J., Jacobs, L. E., Stalenhoef, A., van der Meer, J. W., and van Deuren, M. (2004) Human lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitidis LPS, and complete gram-negative bacteria. J. Lipid Res. 45, 742-749 (Pubitemid 38405681)
5. Kitchens, R. L., Thompson, P. A., Viriyakosol, S., O'Keefe, G. E., and Munford, R. S. (2001) Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J. Clin. Invest. 108, 485-493 (Pubitemid 32730795)
6. Brandenburg, K., Jürgens, G., Andrä, J., Lindner, B., Koch, M. H., Blume, A., and Garidel, P. (2002) Biophysical characterization of the interaction of high-density lipoprotein (HDL) with endotoxins. Eur. J. Biochem. 269, 5972-5981 (Pubitemid 35425595)
7. Cai, L., Ji, A., de Beer, F. C., Tannock, L. R., and van der Westhuyzen, D. R. (2008) SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J. Clin. Invest. 118, 364-375
8. Van Lenten, B. J., Fogelman, A. M., Haberland, M. E., and Edwards, P. A. (1986) The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 83, 2704-2708
9. Van Lenten, B. J., Wagner, A. C., Nayak, D. P., Hama, S., Navab, M., and Fogelman, A. M. (2001) High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation 103, 2283-2288
10. Hyka, N., Dayer, J. M., Modoux, C., Kohno, T., Edwards, C. K. 3rd, Roux-Lombard, P., and Burger, D. (2001) Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97, 2381-2389 (Pubitemid 32291485)
11. Cockerill, G. W., Huehns, T. Y., Weerasinghe, A., Stocker, C., Lerch, P. G., Miller, N. E., and Haskard, D. O. (2001) Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation 103, 108-112
12. Vreugdenhil, A. C., Snoek, A. M., van 't Veer, C., Greve, J. W., and Buurman, W. A. (2001) LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. J. Clin. Invest. 107, 225-234
13. Thompson, P. A., Tobias, P. S., Viriyakosol, S., Kirkland, T. N., and Kitchens, R. L. (2003) Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J. Biol. Chem. 278, 28367-28371
14. Hailman, E., Albers, J. J., Wolfbauer, G., Tu, A. Y., and Wright, S. D. (1996) Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J. Biol. Chem. 271, 12172-12178
15. Gautier, T., Klein, A., Deckert, V., Desrumaux, C., Ogier, N., Sberna, A. L., Paul, C., LeGuern, N., Athias, A., Montange, T., Monier, S., Piard, F., Jiang, X. C., Masson, D., and Lagrost, L. (2008) Effect of plasma phospholipid transfer protein deficiency on lethal endotoxemia in mice. J. Biol. Chem. 283, 18702-18710
16. Tzotzas, T., Desrumaux, C., and Lagrost, L. (2009) Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor. Obes. Rev. 10, 403-411
17. Nishijima, M., Amano, F., Akamatsu, Y., Akagawa, K., Tokunaga, T., and Raetz, C. R. (1985) Macrophage activation by monosaccharide precursors of Escherichia coli lipid A. Proc. Natl. Acad. Sci. U. S. A. 82, 282-286
18. Jeannin, J. F., Onier, N., Lagadec, P., von Jeney, N., Stütz, P., and Liehl, E. (1991) Antitumor effect of synthetic derivatives of lipid A in an experimental model of colon cancer in the rat. Gastroenterology 101, 726-733
19. Onier, N., Hilpert, S., Arnould, L., Saint-Giorgio, V., Davies, J. G., and Jeannin, J. F. (1999) Cure of colon cancer metastasis in rats with the new lipid A OM 174: apoptosis of tumor cells and immunization of rats. Clin. Exp. Metastasis 17, 299-306
20. D'Agostini, C., Pica, F., Febbraro, G., Grelli, S., Chiavaroli, C., and Garaci, E. (2005) Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions. Int. Immunopharmacol. 5, 1205-1212 (Pubitemid 40725714)
21. Jiang, X. C., Bruce, C., Mar, J., Lin, M., Ji, Y., Francone, O. L., and Tall, A. R. (1999) Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 103, 907-914
22. Olsson, N. O., Leclerc, A., Jeannin, J. F., and Martin, F. (1982) A simple photometric microassay for the quantitative evaluation of macrophage-mediated cytotoxicity on adherent cancer cells. Ann. Immunol. (Paris) 133D, 245-254 (Pubitemid 13209515)
23. Szponar, B., Krasńik, L., Hryniewiecki, T., Gamian, A., and Larsson, L. (2003) Distribution of 3-hydroxy fatty acids in tissues after intraperitoneal injection of endotoxin. Clin. Chem. 49, 1149-1153
24. Büchau, A. S., Morizane, S., Trowbridge, J., Schauber, J., Kotol, P., Bui, J. D., and Gallo, R. L. (2010) The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth. J. Immunol. 184, 369-378
25. Buchwald, H. (1992) Cholesterol inhibition, cancer, and chemotherapy. Lancet 339, 1154-1156
26. Guyard-Dangremont, V., Desrumaux, C., Gambert, P., Lallemant, C., and Lagrost, L. (1998) Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species: relation to atherogenesis susceptibility. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 120, 517-525 (Pubitemid 28386764)
27. Lakomy, D., Rébé, C., Sberna, A. L., Masson, D., Gautier, T., Chevriaux, A., Raveneau, M., Ogier, N., Nguyen, A. T., Gambert, P., Grober, J., Bonnotte, B., Solary, E., and Lagrost, L. (2009) Liver X receptor-mediated induction of cholesteryl ester transfer protein expression is selectively impaired in inflammatory macrophages. Arterioscler. Thromb. Vasc. Biol. 29, 1923-1929
28. Vikstedt, R., Ye, D., Metso, J., Hildebrand, R. B., Van Berkel, T. J., Ehnholm, C., Jauhiainen, M., and Van Eck, M. (2007) Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development. Arterioscler. Thromb. Vasc. Biol. 27, 578-586 (Pubitemid 46263403)
29. Klimp, A. H., de Vries, E. G., Scherphof, G. L., and Daemen, T. (2002) A potential role of macrophage activation in the treatment of cancer. Crit. Rev. Oncol. Hematol. 44, 143-161 (Pubitemid 36159043)
30. Brandenburg, K., Lindner, B., Schromm, A., Koch, M. H., Bauer, J., Merkli, A., Zbaeren, C., Davies, J. G., and Seydel, U. (2000) Physicochemical characteristics of triacyl lipid A partial structure OM-174 in relation to biological activity. Eur. J. Biochem. 267, 3370-3377 (Pubitemid 30341167)
31. Brandenburg, K., Mayer, H., Koch, M. H., Weckesser, J., Rietschel, E. T., and Seydel, U. (1993) Influence of the supramolecular structure of free lipid A on its biological activity. Eur. J. Biochem. 218, 555-563 (Pubitemid 24003773)
32. Shnyra, A., Hultenby, K., Lindberg, A. A. (1993) Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxic properties. Infect. Immun. 61, 5351-5360 (Pubitemid 23353919)
33. Sasaki, H., and White, S. H. (2008) Aggregation behavior of an ultra-pure lipopolysaccharide that stimulates TLR-4 receptors. Biophys. J. 95, 986-993
34. Salmon, A. H., Neal, C. R., and Harper, S. J. (2009) New aspects of glomerular filtration barrier structure and function: five layers (at least) not three. Curr. Opin. Nephrol. Hypertens. 18, 197-205
35. Koch, P. J., Frank, J., Schüler, J., Kahle, C., and Bradaczek, H. (1999) Thermodynamics and structural studies of the interaction of polymyxin B with deep rough mutant lipopolysaccharides. J. Colloid Interface Sci. 213, 557-564 (Pubitemid 29394724)
36. Bergstrand, A., Svanberg, C., Langton, M., and Nydén, M. (2006) Aggregation behavior and size of lipopolysaccharide from Escherichia coli O55:B5. Colloids Surf. B Biointerfaces 53, 9-14 (Pubitemid 44584624)
37. Mueller, M., Lindner, B., Kusumoto, S., Fukase, K., Schromm, A. B., and Seydel, U. (2004) Aggregates are the biologically active units of endotoxin. J. Biol. Chem. 279, 26307-26313
38. Seong, S. Y., and Matzinger, P. (2004) Hydrophobicity, an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4, 469-478
39. Ulevitch, R. J., Johnston, A. R., and Weinstein, D. B. (1981) New function for high density lipoproteins: isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. J. Clin. Invest. 67, 827-837
40. Kitchens, R. L., Wolfbauer, G., Albers, J. J., and Munford, R. S. (1999) Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J. Biol. Chem. 274, 34116-34122
41. Levels, J. H., Marquart, J. A., Abraham, P. R., van den Ende, A. E., Molhuizen, H. O., van Deventer, S. J., and Meijers, J. C. (2005) Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein. Infect. Immun. 73, 2321-2326
42. Vesy, C. J., Kitchens, R. L., Wolfbauer, G., Albers, J. J., and Munford, R. S. (2000) Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes. Infect. Immun. 68, 2410-2417
43. Wendel, M., Paul, R., and Heller, A. R. (2007) Lipoproteins in inflammation and sepsis. II. Clinical aspects. Intensive Care Med. 33, 25-35